About this episode

A midyear discussion on the current state and future of the life sciences industry.

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Tyler Menichiello, chief editor at Bioprocess Online, host of the Better Biopharma podcast, and my Life Science Connect (LSC) colleague, convenes the broader LSC editorial team once again for a midyear discussion on what's happening now in the life sciences industry, and what's to come in the second half of the year. Topics include AI manufacturing regulations and navigating supply chain...

People in this episode

Host: Tyler Menichiello

Topics covered

• life sciences industry
• AI manufacturing
• supply chain
• midyear discussion
• regulations

Keywords

• life sciences
• AI
• manufacturing regulations
• supply chain
• midyear review

Mentioned in this episode

Organizations: Bioprocess Online, Life Science Connect, Better Biopharma

Places: 2026

More episodes of Business Of Biotech

• Derisking CNS Drug Development With Tortugas Neuroscience's Jeff Jonas, M.D. · June 1, 2026 · 50 min
• Rare Disease Drug Commercialization With Zevra Therapeutics' Neil McFarlane · May 25, 2026 · 55 min
• Scaling Manufacturing For Personalized Cell Therapies With Cellino's Marinna Madrid, Ph.D. · May 18, 2026 · 51 min
• Building A New Antibody Discovery Platform With Infinimmune's Wyatt McDonnell, Ph.D. · May 11, 2026 · 54 min

Explore listener stats, chart rankings, contacts and more on the Business Of Biotech podcast page.